R

RDNT

RadNet, Inc.
HealthcareMedical - Diagnostics & Research|NASDAQ Global Market|US

Price

$54.79

Market Cap

$4.25B

Beta

1.46

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+11.51%
EPS Growth (YoY)-100.00%
Revenue CAGR 3Y+12.57%
P/E Ratio0.0
PEG Ratio
FCF Yield-4.20%
Debt / Equity1.71
Interest Coverage0.9x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for RDNT.

RDNT — RadNet, Inc. Stock Analysis | Tessera Alpha